Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/11223
Full metadata record
DC FieldValueLanguage
dc.contributor.authorJackson, B-
dc.contributor.authorFabris, Bruno-
dc.contributor.authorPaxton, D-
dc.contributor.authorFranze, L-
dc.contributor.authorJohnston, Colin I-
dc.date.accessioned2015-05-16T00:48:42Z
dc.date.available2015-05-16T00:48:42Z
dc.date.issued1990-03-01-
dc.identifier.citationClinical and Experimental Pharmacology & Physiology; 17(3): 229-34en_US
dc.identifier.otherPUBMEDen
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/11223en
dc.description.abstract1. To dissociate the effects on the development of diabetic renal injury of angiotensin converting enzyme (ACE) inhibition per se, and a reduction in systemic blood pressure, we have studied the effects of chronic ramapril treatment in streptozotocin diabetic spontaneously hypertensive rats, with modulation of the hypotensive effect by a high salt diet. 2. Three weeks following uninephrectomy and induction of diabetes with streptozotocin, spontaneously hypertensive rats were allocated to three treatment groups. Groups 1 and 2 received 1% sodium chloride and Group 3 water as drinking solution. Groups 2 and 3 received 0.4 mg/kg per day ramapril in drinking solution over the subsequent 2 month study period. 3. Sodium chloride drinking solution (1%) completely prevented any hypotensive effect of ramapril. Blood pressure was reduced in Group 3 rats over the entire period of study, when compared with Group 2 rats (P less than 0.001). 4. Urinary protein excretion progressively increased in Group 1 and 2 rats, and was significantly reduced (P less than 0.001) in Group 3. After 2 months treatment, urinary protein (expressed as mean and s.e.m.) was 160 +/- 30 mg/day in Group 1, 240 +/- 50 mg/day in Group 2, and 60 +/- 11 mg/day in Group 3. 5. Angiotensin converting enzyme inhibition per se was not associated with a reduced protein excretion in diabetic nephropathy, requiring concomitant control of systemic blood pressure to become renoprotective.en_US
dc.language.isoenen
dc.subject.otherAnimalsen
dc.subject.otherBicyclo Compounds.pharmacologyen
dc.subject.otherBlood Pressure.drug effectsen
dc.subject.otherBridged Compounds.pharmacologyen
dc.subject.otherDiabetes Mellitus, Experimental.physiopathologyen
dc.subject.otherGlomerular Filtration Rate.drug effectsen
dc.subject.otherMaleen
dc.subject.otherProteinuria.etiologyen
dc.subject.otherRamiprilen
dc.subject.otherRatsen
dc.subject.otherRats, Inbred SHRen
dc.subject.otherSodium, Dietary.pharmacologyen
dc.subject.otherStreptozocinen
dc.subject.otherTime Factorsen
dc.titleHigh salt diet ameliorates effects of angiotensin converting enzyme inhibition in spontaneously hypertensive streptozotocin diabetic rats.en_US
dc.typeJournal Articleen_US
dc.identifier.journaltitleClinical and Experimental Pharmacology & Physiologyen_US
dc.identifier.affiliationMedicine (University of Melbourne)en_US
dc.description.pages229-34en
dc.relation.urlhttps://pubmed.ncbi.nlm.nih.gov/2140303en
dc.type.contentTexten_US
dc.type.austinJournal Articleen
local.name.researcherJackson, Belinda D
item.fulltextNo Fulltext-
item.openairetypeJournal Article-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.grantfulltextnone-
item.languageiso639-1en-
item.cerifentitytypePublications-
crisitem.author.deptGastroenterology and Hepatology-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

22
checked on Dec 21, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.